-
chemical name
ethyl eicosapentaenoic acid (E-EPA), sold
under the
brand name
Vascepa among others, is a
medication used to
treat dyslipidemia and hypertriglyceridemia...
-
developed the drug
Vascepa (AMR-101), a
prescription grade omega-3
fatty acid. In July 2012,
their lead-candidate drug
named Vascepa (AMR-101) received...
- hypertriglyceridemia,
namely Lovaza,
Omtryg (both omega-3-acid
ethyl esters),
Vascepa (ethyl
eicosapentaenoic acid), and
Epanova (omega-3-carboxylic acids)....
- omega−3-acid
ethyl esters (Lovaza and Omtryg) and
ethyl eicosapentaenoic acid (
Vascepa), to be
approved for use as a drug. The
first approval in the
United States...
-
claims of
preventing heart attacks or strokes, a
recent multi-year
study of
Vascepa (ethyl eicosapentaenoate, the
ethyl ester of the free
fatty acid), a prescription...
- hypertriglyceridemia,
namely Lovaza,
Omtryg (both omega-3-acid
ethyl esters),
Vascepa (ethyl
eicosapentaenoic acid), and
Epanova (omega-3-carboxylic acids)....
-
around the
marketing of
ethyl eicosapentaenoic acid (E-EPA,
branded as "
Vascepa") by
Amarin Corporation led to a 2015
court decision that has
changed the...
- have
similar uses and
mechanisms of action.
Ethyl eicosapentaenoic acid (
Vascepa). EPA-only
ethyl esters. Omega-3-carboxylic
acids (Epanova). This product...
-
Honey Varibar Thin
Liquid Varithena Varivax varlitinib (USAN, INN)
Varubi Vascepa Vascor Vascoray Vaseretic Vasocidin Vasoclear Vasocon-A
Vasocon Vasodilan...
-
Litigation around the
marketing of
ethyl eicosapentaenoic acid (branded as "
Vascepa") by
Amarin Corporation led to a 2015
court decision that
changed the FDA's...
